logo
Questions, questions, questions…
Reflections after the Diane affair
Contraceptive pills and thrombosis: effects of the French crisis on prescriptions and consequences for medicine agencies
Pneumonia, thrombosis and vascular disease
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial
Dynamics of vitamin K antagonist and new oral anticoagulants use in atrial fibrillation: a Danish drug utilization study
Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials
Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now?
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome
Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study
Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study
Below-knee cast immobilization and the risk of venous thrombosis: results from a large population-based case–control study
Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis
No increased systemic fibrinolysis in women with heavy menstrual bleeding
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease
Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors
Single-chain factor XII exhibits activity when complexed to polyphosphate
A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay
IKKβ regulates endothelial thrombomodulin in a Klf2-dependent manner
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays
Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children
Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe hemophiliacs
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey
Monitoring the anticoagulant effect after a massive rivaroxaban overdose
The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: comment
The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: reply
Philip J. Fay (1953–2014)
Join ISTH